HLA-B27 is a Risk Factor for Rheumatoid Arthritis: Suggestion for an Evidence-based Update

Yasin Ahmadi, Seyyed Amir and Mohammadrezaei-Khorramabadi, Reza and Abbaszadeh, Saber and Rezaian, Jafar and Shahsavar, Farhad (2019) HLA-B27 is a Risk Factor for Rheumatoid Arthritis: Suggestion for an Evidence-based Update. Current Pharmacogenomics and Personalized Medicine.

[img]
Preview
Text
004AF.pdf

Download (876kB) | Preview

Abstract

A R T I C L E H I S T O R Y Received: December 20, 2018 Revised: February 08, 2019 Accepted: March 08, 2019 DOI: 10.2174/1875692117666190408113012 Abstract: Previously, the association of human leukocyte antigen (HLA)-B27 with ankylosing spondylitis has been investigated as original and meta-analysis studies. However, the association of HLA-B27 with rheumatoid arthritis is not currently investigated as a meta-analysis. Hence, in this letter, a brief meta-analysis on this association will be performed. Although there were some studies on the association of RA and HLA-B27, however, there was not a pooled odds ratio reported in textbooks. Based on this brief metaanalysis, number 2.687 can be reported as the odds ratio of this association. It shows that this association is neither sensitive nor specific, but can be an idea for pharmacogenomics and personalized medicine as a potential risk factor. Such other associations should be reported numerically and updated in textbooks. Keywords: HLA-B27, rheumatoid arthritis, meta-analysis, personalized medicine, human leukocyte antigen, immunogenic peptides

Item Type: Article
Subjects: R Medicine > RB Pathology
Divisions: Faculty of Medicine, Health and Life Sciences > School of Medicine
Depositing User: lorestan university
Date Deposited: 17 May 2020 06:31
Last Modified: 17 May 2020 06:31
URI: http://eprints.lums.ac.ir/id/eprint/2094

Actions (login required)

View Item View Item